Sunshine hours and utilization of benzodiazepines
Authors:
- Srđan Z. MarkovićSMSrđan Z. Marković
- Đura J. NakaradaĐNĐura J. Nakarada
- Miloš D. MojovićMiloš D. Mojović
- Mirjana M. BeljićMBMirjana M. Beljić
- Mira H. VukovićMVMira H. Vuković
- Dragana A. KastratovićDKDragana A. Kastratović
Open Access
- 1 January 2021
- journal article
- research article
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Hospital Pharmacology - International Multidisciplinary Journal
- Vol. 8 (2) , 1032-1040
Abstract
Introduction: Benzodiazepines belong to the group of anxiolytic sedatives and the most prescribed drugs in the world. The authors conducted this pilot study based n large number of patients reports that they were less anxious and felt better overall by migrating to sunnier environments. Aim: We estimated the impact of the total sunshine hours per month on daily exposure of the population to Benzodiazepine anxiolytic on a monthly basis in the Republic of Serbia. Material and Methods: We conducted a retrospective academic IV phase study, which tested the correlation of time series of monthly sold Benzodiazepine anxiolytics in pharmacies and total sunshine hours per month in the Republic of Serbia, from January 2014 to May 2019. Results: According to the seasons, we did not find any difference in the increase of the population exposure to benzodiazepines. A difference was found between bromazepam consumption compared to cumulative monthly. Bromazepam consumption was negatively correlated with the cumulative monthly sunshine hours. The cutoff value for bromazepam was 131.45 cumulative monthly sunshine hours. Conclusion: This is the first pharmaco-epidemiologic study to prove that the population's exposure to benzodiazepines, in addition to the implicit health and economic effects on physicians' prescribing habits for these drugs, can be independently linked to the cumulative effects of monthly sunshine hours on the population. No difference in Benzodiazepine consumption was found in relation to the seasons (spring/summer vs autumn/winter). In months where sunshine hours was ≥135.45, the need for bromazepam was significantly reduced. Seasonal variation of climatic effects of total monthly sunshine hours is significantly correlated with the population's need for benzodiazepines with anxiolytic effects longer than 12 hours.Keywords
This publication has 10 references indexed in Scilit:
- It’s Sunny, Be Healthy? An International Comparison of the Influence of Sun Exposure and Latitude Lines on Self-Rated HealthInternational Journal of Environmental Research and Public Health, 2021
- Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial ProtocolFrontiers in Psychiatry, 2020
- Who diagnosed and prescribed what? Using provider details to inform observational researchPharmacoepidemiology and Drug Safety, 2018
- Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and AlternativesJournal of Clinical Medicine, 2018
- Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014JAMA Psychiatry, 2017
- Why We Need More Nature at Work: Effects of Natural Elements and Sunlight on Employee Mental Health and Work AttitudesPLOS ONE, 2016
- Prevalence, behavioral manifestations and associated individual and climatic factors of seasonality in the Korean general populationComprehensive Psychiatry, 2015
- Serum BDNF Concentrations Show Strong Seasonal Variation and Correlations with the Amount of Ambient SunlightPLOS ONE, 2012
- Utilization, Spending, and Price Trends for Benzodiazepines in the US Medicaid Program: 1991-2009Annals of Pharmacotherapy, 2012
- Panic anxiety, under the weather?International Journal of Biometeorology, 2004